Orchestra BioMed

Orchestra BioMed is a biomedical innovation company based in the United States that focuses on developing transformative therapeutic products for unmet clinical needs in procedure-based medicine. The company has approximately 60 employees and utilizes a partnership-enabled business model to accelerate the commercialization of its innovative product pipeline, which includes two late-stage flagship technologies for the treatment of hypertension and atherosclerotic artery disease.